Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alignment Healthcare (ALHC) Other Non-Current Assets (2020 - 2025)

Historic Other Non-Current Assets for Alignment Healthcare (ALHC) over the last 6 years, with Q3 2025 value amounting to $6.3 million.

  • Alignment Healthcare's Other Non-Current Assets fell 251.23% to $6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year decrease of 251.23%. This contributed to the annual value of $6.1 million for FY2024, which is 488.68% down from last year.
  • Latest data reveals that Alignment Healthcare reported Other Non-Current Assets of $6.3 million as of Q3 2025, which was down 251.23% from $6.3 million recorded in Q2 2025.
  • Alignment Healthcare's 5-year Other Non-Current Assets high stood at $6.8 million for Q1 2024, and its period low was $2.2 million during Q1 2021.
  • Its 5-year average for Other Non-Current Assets is $5.6 million, with a median of $6.1 million in 2024.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first skyrocketed by 13116.58% in 2022, then tumbled by 952.66% in 2025.
  • Alignment Healthcare's Other Non-Current Assets (Quarter) stood at $4.7 million in 2021, then rose by 28.16% to $6.0 million in 2022, then rose by 6.13% to $6.4 million in 2023, then dropped by 4.89% to $6.1 million in 2024, then rose by 3.82% to $6.3 million in 2025.
  • Its last three reported values are $6.3 million in Q3 2025, $6.3 million for Q2 2025, and $6.1 million during Q1 2025.